LOXL2 and esophageal squamous cell carcinoma: The results show that LCN2, MMP9 and LOXL2 were highly co‐expressed at protein level in 80% (16/20) ESCC clinical samples, and they illustrated a strong cytoplasm staining (Fig. S2).